Pages that link to "Q47416325"
Jump to navigation
Jump to search
The following pages link to Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy (Q47416325):
Displaying 10 items.
- Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy. (Q38694553) (← links)
- Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs (Q38746272) (← links)
- d-Leucine: Evaluation in an epilepsy model (Q47622804) (← links)
- Inhibition of astroglial connexin43 hemichannels with TAT-Gap19 exerts anticonvulsant effects in rodents. (Q52570599) (← links)
- Recurrent epileptiform discharges in the medial entorhinal cortex of kainate-treated rats are differentially sensitive to antiseizure drugs (Q57453122) (← links)
- A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force (Q59137534) (← links)
- Proceedings of the Epilepsy Foundation's 2017 Cannabinoids in Epilepsy Therapy Workshop (Q89125092) (← links)
- Zebrafish-Based Discovery of Antiseizure Compounds from the North Sea: Isoquinoline Alkaloids TMC-120A and TMC-120B (Q91298373) (← links)
- Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources (Q92396128) (← links)
- Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine-resistant amygdala kindling model (Q92803726) (← links)